NOCICEPTIVE TRANSMISSION IN THE SPINAL CORD

脊髓中的伤害性传播

基本信息

  • 批准号:
    3069496
  • 负责人:
  • 金额:
    $ 9.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1988
  • 资助国家:
    美国
  • 起止时间:
    1988-04-01 至 1993-03-31
  • 项目状态:
    已结题

项目摘要

The long term goal of this plan is to clarify, in discrete areas of the spinal cord, the interrelationships of transmitter candidates that appear to be involved in pain and analgesia. Substance P (SP) and excitatory amino acids (EAA) appear to participate in pain- transmission and endogenous analgesia. We are currently using a combination of biochemical, anatomical and behavioral approaches to focus on the roles of these compounds in pain and analgesia. The goal of our present work on SP is to determine the mechanism of desensitization to SP. Analgesic drugs may then be designed which mimic or exploit such desensitization. The specific objectives are to correlate changes in desensitization to SP with changes in the concentration of specific SP metabolites and in SP binding. The goals of our EAA studies are to elucidate the role that EAAs play in transmission along primary afferent and/or centrally projecting fibers involved in pain-transmission and to determine whether such EAA neurotransmission is specifically affected by opioid and non-opioid compounds. The specific objectives are to characterize the distribution (immunostaining), concentration (HPLC) and release (potassium-evoked changes in extracellular fluid) of EAAs in areas of the CNS presumed to be involved in pain transmission and their relation to endogenously occurring antinociceptive mechanisms. Our long term plans are to extend our present research examining transmitter release during nociceptive and antinoceptive processing in discrete areas of the spinal cord. The system currently in use in our laboratory involves the implantation of a semipermeable dialysis tubing through the spinal cord and provides us with an excellent method of examining extracellular fluid as a reflection of transmitter release. Compounds or mainpulations presumed to alter pain or transmitter release can then be tested in vivo. While our present studies focus on EAA release in the rat spinal cord, our long term goal is to use larger species, such as cat, to examine the release of not only EAAs but also that of SP, SP metabolites and serotonin from even more discrete regions and from any two distinct areas simultaneously. The experiments described will integrate our current research programs and expand their scope. This research will contribute to our understanding of neurotransmission by SP and EAAs.
这个计划的长期目标是澄清,在离散的领域

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALICE A LARSON其他文献

ALICE A LARSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALICE A LARSON', 18)}}的其他基金

Urocortin & Musculoskeletal Hyperalgesia
尿皮质素
  • 批准号:
    7989277
  • 财政年份:
    2010
  • 资助金额:
    $ 9.47万
  • 项目类别:
Urocortin & Musculoskeletal Hyperalgesia
尿皮质素
  • 批准号:
    7939609
  • 财政年份:
    2009
  • 资助金额:
    $ 9.47万
  • 项目类别:
Urocortin & Musculoskeletal Hyperalgesia
尿皮质素
  • 批准号:
    7579636
  • 财政年份:
    2009
  • 资助金额:
    $ 9.47万
  • 项目类别:
Urocortin & Musculoskeletal Hyperalgesia
尿皮质素
  • 批准号:
    8139097
  • 财政年份:
    2009
  • 资助金额:
    $ 9.47万
  • 项目类别:
Urocortin & Musculoskeletal Hyperalgesia
尿皮质素
  • 批准号:
    8537101
  • 财政年份:
    2009
  • 资助金额:
    $ 9.47万
  • 项目类别:
Urocortin & Musculoskeletal Hyperalgesia
尿皮质素
  • 批准号:
    8325445
  • 财政年份:
    2009
  • 资助金额:
    $ 9.47万
  • 项目类别:
NEUROTROPHINS AND AN ANIMAL MODEL OF FIBROMYALGIA
神经营养因子和纤维肌痛动物模型
  • 批准号:
    2843921
  • 财政年份:
    1999
  • 资助金额:
    $ 9.47万
  • 项目类别:
NEUROTROPHINS AND AN ANIMAL MODEL OF FIBROMYALGIA
神经营养因子和纤维肌痛动物模型
  • 批准号:
    6188739
  • 财政年份:
    1999
  • 资助金额:
    $ 9.47万
  • 项目类别:
NEUROTROPHINS AND AN ANIMAL MODEL OF FIBROMYALGIA
神经营养因子和纤维肌痛动物模型
  • 批准号:
    6394320
  • 财政年份:
    1999
  • 资助金额:
    $ 9.47万
  • 项目类别:
NEUROTROPHINS AND AN ANIMAL MODEL OF FIBROMYALGIA
神经营养因子和纤维肌痛动物模型
  • 批准号:
    6540221
  • 财政年份:
    1999
  • 资助金额:
    $ 9.47万
  • 项目类别:

相似海外基金

Unravelling the neural basis of breathing, respiratory depression, and analgesia by opioid drugs.
揭示阿片类药物呼吸、呼吸抑制和镇痛的神经基础。
  • 批准号:
    479039
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Operating Grants
Dissociating respiratory depression and analgesia via a data-driven model of interacting respiratory and pain networks
通过呼吸和疼痛网络相互作用的数据驱动模型分离呼吸抑制和镇痛
  • 批准号:
    10644300
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Elucidating causal mechanisms of ethanol-induced analgesia in BXD recombinant inbred mouse lines
阐明 BXD 重组近交系小鼠乙醇诱导镇痛的因果机制
  • 批准号:
    10825737
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia
DOR-KOR 异聚体介导的外周镇痛变构分子的鉴定
  • 批准号:
    10608439
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Evaluation of the Role of Macrophage Migratory Inhibitory Factor (MIF) in mediating Stem Cell Analgesia in a Model of Orofacial Pain
评估巨噬细胞迁移抑制因子(MIF)在口面部疼痛模型中介导干细胞镇痛的作用
  • 批准号:
    10585412
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Study: A Pilot Randomized Controlled Trial
裸盖菇素用于增强慢性神经病性疼痛 (PEACE-PAIN) 镇痛效果的研究:一项随机对照试验
  • 批准号:
    479442
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Operating Grants
Development of a regional anesthesia guidance system to increase patient access to opioid-sparing analgesia for hip fracture pain
开发区域麻醉引导系统,以增加患者获得髋部骨折疼痛的阿片类药物保留镇痛的机会
  • 批准号:
    10759550
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Maintaining opioid analgesia and preventing addiction with hypocretin antagonism
通过下丘脑分泌素拮抗作用维持阿片类药物镇痛并预防成瘾
  • 批准号:
    10713175
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Disease Modifying Analgesia with CA8 Gene Therapy
CA8 基因治疗的疾病修饰镇痛
  • 批准号:
    10710264
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Circuit mechanisms for opioid analgesia and addiction in prefrontal cortex
前额皮质阿片类镇痛和成瘾的回路机制
  • 批准号:
    10607118
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了